Distinguished in Gitelman Syndrome

Leonardo A. Calo

Department Of Surgical Sciences For Diseases Of The Head And Neck, 
Rome, IT 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Gitelman Syndrome
Department Of Surgical Sciences For Diseases Of The Head And Neck, 
Rome, IT 
OverviewLocationsClinical Research

Overview

Leonardo Calo practices in Rome, Italy. Mr. Calo is rated as a Distinguished expert by MediFind in the treatment of Gitelman Syndrome. His top areas of expertise are Heart Block, Brugada Syndrome, Cardiomyopathy, Cardiac Ablation, and Pacemaker Implantation.

His clinical research consists of co-authoring 300 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Gitelman Syndrome.

Gender
Male

Locations

Department Of Surgical Sciences For Diseases Of The Head And Neck, Rome, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

CRT-DRIVE: Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
CRT-DRIVE: Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
Enrollment Status: Recruiting
Publish Date: October 24, 2024
Intervention Type: Device
Study Phase: Not Applicable
Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction
Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction
Enrollment Status: Completed
Publish Date: March 24, 2025
Intervention Type: Device
Study Phase: Not Applicable
Atrial Fibrillation Progression Trial
Atrial Fibrillation Progression Trial
Enrollment Status: Terminated
Publish Date: February 04, 2025
Intervention Type: Device, Drug
Study Phase: Phase 4
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)
Enrollment Status: Completed
Publish Date: October 25, 2023
Intervention Type: Device
Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Persistent Atrial Fibrillation: a Prospective Multi-centre Randomized Controlled Clinical Study
Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Persistent Atrial Fibrillation: a Prospective Multi-centre Randomized Controlled Clinical Study
Enrollment Status: Completed
Publish Date: July 11, 2022
Intervention Type: Drug, Other
Study Phase: Not Applicable
Prevalence of Familial Hypercholesterolaemia (FH) in Italian Patients With Coronary Artery Disease
Prevalence of Familial Hypercholesterolaemia (FH) in Italian Patients With Coronary Artery Disease
Enrollment Status: Completed
Publish Date: October 09, 2020
Efficacy of Transcatheter Ablation Using Anatomic Approach of Ganglionated Plexi Located in the Right Atrium to Prevent Neuromediated Cardioinhibitory Syncope
Efficacy of Transcatheter Ablation Using Anatomic Approach of Ganglionated Plexi Located in the Right Atrium to Prevent Neuromediated Cardioinhibitory Syncope
Enrollment Status: Completed
Publish Date: April 27, 2020
Intervention Type: Procedure
Study Phase: Not Applicable
View 6 Less Clinical Trials

300 Total Publications

The cardiovascular risk of doping and substance abuse in athletes.
The cardiovascular risk of doping and substance abuse in athletes.
Journal: The Journal of sports medicine and physical fitness
Published: October 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Calo's expertise for a condition
ConditionClose
View All 11 Distinguished Conditions
View All 12 Advanced Conditions
View All 36 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile